Octreotide Acetate Injection, Solution
Product Images NDC 68083-517

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Octreotide Acetate (NDC 68083-517). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Octreotide-acetate-spl-carton-label-100-mcg (Octreotide Acetate Spl Carton Label 100 Mcg)

Octreotide Acetate Injection 100 mcg/mL packaging label for single-dose vials, 10 x 1 mL. The label indicates the product is for subcutaneous or intravenous use and is manufactured by Gland Pharma Limited. It includes storage instructions and inactive ingredients, as well as the NDC number 68083-517-10 and Rx only designation.*

FDA Label Image

Octreotide-acetate-spl-carton-label-500-mcg (Octreotide Acetate Spl Carton Label 500 Mcg)

Label for Octreotide Acetate Injection 500 mcg/mL, an injectable solution for subcutaneous or intravenous use. The packaging is for 10 single-dose vials of 1 mL each. The label includes inactive ingredients, storage instructions, and is manufactured by Gland Pharma Limited, Hyderabad, India. The NDC is 68083-560-10.*

FDA Label Image

Octreotide-acetate-spl-vial-label-100-mcg (Octreotide Acetate Spl Vial Label 100 Mcg)

Label for Octreotide Acetate Injection 100 mcg/mL, a solution for injection presented in a 1 mL single-dose vial. The label indicates the drug is for subcutaneous or intravenous use and advises discarding any unused portion. Manufactured by Gland Pharma Limited, Hyderabad, India, the label includes the NDC 68083-517-01 and a barcode.*

FDA Label Image

Octreotide-acetate-spl-vial-label-500-mcg (Octreotide Acetate Spl Vial Label 500 Mcg)

Label for Octreotide Acetate Injection 500 mcg/mL. The label indicates the product contains 500 mcg octreotide (as acetate) per 1 mL in a single-dose vial for subcutaneous or intravenous use. Manufactured by Gland Pharma Limited, Hyderabad, India. Includes an NDC barcode and space for lot and expiration information.*

FDA Label Image

Octreotide-structure (Octreotide Structure)

Chemical structure diagram showing the peptide sequence of Octreotide Acetate, including its amino acid components and variable group x, where x ranges from 1.4 to 2.5.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.